Wallace D. C., et al.
Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta. 1995 May 24; 1271(1):141–51. doi:10.1016/0925-4439(95)00021-U.Walter L., et al.
Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J Biol Chem. 2000 July 10; 275:29521–7. doi:10.1074 /jbc.M004128200.Wei Y. H.
Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med. 1998 Jan; 217(1):53–63.Wei Y. H., Kao S. H., Lee H. C.
Simultaneous increase of mitochondrial DNA deletions and lipid peroxidation in human aging. Ann NY Acad Sci. 1996 Jun 15; 786:24–43. doi:10.1111/j.1749–6632.1996.tb39049.x.Wolvetang E. J., et al.
Mitochondrial respiratory chain inhibitors induce apoptosis. 1994 Feb 14; 339(1–2):40–4. doi:10.1016/0014-5793(94)80380-3.Zhang C., et al.
Varied prevalence of age-associated mitochondrial DNA deletions in different species and tissues: a comparison between human and rat. Biochem Biophys Res Comm. 1997 Jan; 230(3):630–5. doi:10.1006/ bbrc.1996.6020.Глава 3
Ames B. N., Atamna H., Killilea D. W.
Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging. Mol Aspects Med. 2005 Aug — Oct; 26(4–5):363–78. doi:10.1016/j.mam.2005.07.007.Aw T. Y., Jones D. P.
Nutrient supply and mitochondrial function. Annu Rev Nutr. 1989 Jul; 9:229–51. doi:10.1146/annurev.nu.09.070189.001305. Williams K. L., et al. Differing effects of metformin on glycemic control by race-ethnicity. J Clin Endocrinol Metab. 2014 Sep; 99(9):3160–8. Epub 2014 June 12. doi:10.1210/jc.2014–1539.D-рибоза
Andreoli S. P.
Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediatr Res. 1989 Jan; 25(1):97–101. doi:10.1203/00006450-198901000-00021.Asimakis G., et al.
Postischemic recovery of mitochondrial adenine nucleotides in the heart. Circulation. 1992 Jul; 85(6):2212–20.Baldwin D., et al.
Myocardial glucose metabolism and ATP levels are decreased two days after global ischemia. J Surg Res. 1996 Jun; 63(1):35–8. doi:10.1006/jsre.1996.0218.Befera N., et al.
Ribose treatment preserves function of the remote myocardium after myocardial infarction. J Surg Res. 2007 Feb; 137(2):156. doi:10.1016/j.jss.2006.12.022.Bengtsson A., Heriksson K. G., Larsson J.
Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arth Rheum. 1986 Jul; 29(7):817–21. doi:10.1002/art.1780290701.Bengtsson A., Henriksson K. G.
The muscle in fibromyalgia — a review of Swedish studies. J Rheumatol Suppl. 1989 Nov; 19:144–9.Brault J. J., Terjung R. L.
Purine salvage to adenine nucleotides in different skeletal muscle fiber types. J Appl Physiol. 2001; 91:231–8.Chatham J. C., et al.
Studies of the protective effect of ribose in myocardial ischaemia by using 31P-nuclear magnetic resonance spectroscopy. Biochem Soc Proc. 1985 Oct; 13(5):885–8. doi:10.1042/bst0130885.Clay M. A., et al.
Chronic alcoholic cardiomyopathy. Protection of the isolated ischemic working heart by ribose. Biochem Int. 1988 Nov; 17(5):791–800.Dodd S. L., et al.
The role of ribose in human skeletal muscle metabolism. Med Hypotheses. 2004; 62(5):819–24. doi:10.1016/j.mehy.2003.10.026.Dow J., et al.
Adenine nucleotide synthesis de novo in mature rat cardiac myocytes. Biochim Biophys Acta. 1985 Nov 20; 847(2):223–7. doi:10.1016/0167-4889(85)90024-2.Ellison G. M., et al.
Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart (British Cardiac Society). 2012 Jan; 98(1):5–10.Enzig S., et al.
Myocardial ATP repletion with ribose infusion. Pediatr Res. 1985; 19:127A.Gebhart B., Jorgenson J. A.
Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy. 2004 Nov; 24(11):1646–8. doi:10.1592/ phco.24.16.1646.50957.Gross M., Kormann B., Zollner N.
Ribose administration during exercise: effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency. Klin Wochenschr. 1991; 69(4):151–5.Harmsen E., et al.
Enhanced ATP and GTP synthesis from hypoxanthine or inosine after myocardial ischemia. Am J Physiol. 1984 Jan; 246(1 Pt 2): H37–H43.